Developer docs
API playgroundTry for free, no card

Search company profiles

LETI Pharma

Full company profile

uuid000eqrm

Namestring
LETI Pharma
Legal namestring
LETI Pharma, S.L.U.
Websiteurl
leti.de
Company typeenum
Private
Founded yearint
1919
Descriptiontext

LETI Pharma, S.L.U. is a privately-held Spanish pharmaceutical company headquartered in Spain and founded in 1919 by a doctor and a pharmacist, focused on the intersection of dermatology and immunology. The company develops, manufactures, and distributes prescription-adjacent medical skincare and allergen-specific immunotherapies, targeting patients with atopic dermatitis (neurodermitis), sensitive or reddened skin including rosacea subtype I, very dry or compromised skin, and allergies such as pollen or house dust mite. The company celebrated its 100th anniversary in 2019 and operates as a family-owned business with continuous research activity since founding.

The product portfolio is organized into three dermatology lines — LETI AT4 (atopic-prone skin, addressing the four symptoms of dryness, itching, irritation, and superinfection risk, formulated with prebiotics such as alpha-glucan oligosaccharide, bisabolol, and barrier-repair ingredients), LETI SR (vascular protection line for rosacea and couperose using probiotic Lactobacillus Ferment), and LETI balm (intensive barrier repair with ceramides and 20% urea foot care) — alongside Hyposensibilisierung allergen-specific immunotherapy (SIT) offerings for causal allergy treatment. LETI AT4 has been clinically tested in over 50 studies, with reported user-survey outcomes including a 92% recommendation rate and 56% reduction in itching among children with neurodermitis.

The business model rests on B2B sales to the German pharmacy channel under AGB agreements, supported by an external sales force and pre-printed order forms; a separate Fachkreise (professional healthcare) channel — gated by DocCheck authentication — supplies physicians with diagnostic tools and customized SIT preparations ordered through a proprietary online portal (vacunas.leti.com) and delivered directly to practices. Distribution is executed by Health Logistics in Bruchsal, and products are additionally listed across at least nine German online pharmacy marketplaces (Shop Apotheke, DocMorris, Medpex, Aponeo, Apotal, Volksversand, Medikamente-per-Klick, MyCare, Apodiscounter). Revenue is generated from one-time product sales across all three segments (skincare, immunotherapy preparations, and diagnostic products), with no subscription or licensing pricing model disclosed. Pricing is not publicly disclosed and varies by pharmacy retail channel.

Short descriptiontext

LETI Pharma is a privately-held Spanish pharmaceutical company founded in 1919 that develops and distributes medical skincare (LETI AT4, LETI SR, LETI balm) and allergen-specific immunotherapies through German pharmacies and online platforms for patients with atopic dermatitis, rosacea, dry skin, and allergies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersIsmaning, Germany
HQ citystring
Ismaning
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
dermatological skincare, allergen immunotherapy, atopic dermatitis care, medical skin care, allergy therapeutics
Industry5 codes
PRIMARYHLAIAAAK
Dermatology & Aesthetics Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYCRABAAAF
Dermocosmetics & Medical-Grade Skincare
SECONDARYCRABAAAG
Sensitive Skin & Barrier Repair
SECONDARYHLAIACAL
Dermatology Specialty Pharmaceuticals
SECONDARYCRADAMAF
Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
NAICS code3 codes
  • Pharmaceutical and Medicine Manufacturing3254
  • Pharmaceutical Preparation Manufacturing325412
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
SIC code2 codes
  • Perfumes, Cosmetics & Other Toilet Preparations2844
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Dermatological Pharmaceuticals
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Skincare Products
TypeOne Time License
Description

Sale of medical skincare products (LETI AT4, LETI SR, LETI balm lines) to pharmacies and end consumers through pharmacy channel.

leti.de
2Specific Immunotherapy (SIT)
TypeOne Time License
Description

Customized allergen immunotherapy preparations for allergy treatment, ordered through physicians and delivered to practices or pharmacies.

leti.de
3Diagnostic Products
TypeOne Time License
Description

Sale of diagnostic tools for healthcare professionals in the Fachkreise (professional) segment.

leti.de
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1LETI AT4
Description

Dermatological skincare line specifically developed for dry skin prone to atopic dermatitis (neurodermatitis). The AT stands for 'Atopic' and the 4 represents the effectiveness against the 4 typical symptoms of atopic dermatitis: skin dryness, itching, skin irritations, and tendency to superinfections.

leti.de
+2 more records
Core offering1 text field

LETI Pharma researches, develops, manufactures, and sells medical skincare products under three sub-brands — LETI AT4 (atopic-prone skin), LETI SR (sensitive/reddened skin and rosacea subtype I), and LETI balm (very dry and rough skin) — and provides allergen-specific immunotherapy (hyposensibilisierung) preparations for the causal treatment of pollen, house dust mite, and other allergies. Products are distributed primarily through pharmacies and physician practices across Germany and Western Europe, with a dedicated professional (Fachkreise) channel supplying diagnostic tools and customized immunotherapy to dermatologists and allergists.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 92% of users recommend LETI AT4 products (n=871, user survey trnd/TERRITORY GmbH, 01/2022)
+5 more records
Product overview1 text field

LETI Pharma is a Spanish pharmaceutical company founded in 1919 specializing in allergy treatments and medical skin care. The company operates three core product lines: (1) LETI AT4 - a comprehensive skin care range specifically formulated for dry, atopic-prone skin (atopic dermatitis/neurodermitis), addressing four key symptoms: skin dryness, itching, irritation, and tendency toward superinfections; (2) LETI SR - products for sensitive and reddened skin, couperose, and rosacea subtype I, offering double vascular protection; and (3) LETI balm - intensive care for very dry and rough skin with products for body, feet, lips, and nasal areas. Additionally, LETI Pharma offers allergen-specific immunotherapy (hyposensibilisierung) as a causal allergy treatment. Products are distributed through pharmacies and specialized online pharmacy platforms in Germany.

Product and service4 records
1LETI AT4
CategoryMedical skincare for atopic dermatitis
Description

Medical skincare line for dry skin prone to atopic dermatitis (neurodermitis). Addresses the four typical symptoms — skin dryness, itching, skin irritations, and tendency toward superinfections — by repairing the skin barrier and restoring microbiome balance using prebiotic alpha-glucan oligosaccharide, bisabolol, and skin-barrier repair ingredients. Range includes shower/bath gel, intensive cream, body lotion, facial cream, and eye lid gel. Indicated for babies from 3 months, children, and adults.

2LETI SR
CategoryMedical skincare for sensitive/reddened skin and rosacea
Description

Medical skincare line for sensitive and reddened skin, including couperose and rosacea subtype I. Provides dual vascular protection that stabilizes capillary walls and strengthens supporting connective tissue, using probiotic Lactobacillus Ferment. Range includes micellar cleansing water, anti-redness serum, mineral SPF 30 facial cream, and an on-the-go anti-redness facial spray. Clinically tested to reduce redness and support skin recovery after facial laser treatments.

3LETI balm
CategoryMedical skincare for very dry and rough skin
Description

Medical skincare line for very dry, rough, or stressed skin on the body, feet, lips, and peribucal area. Ceramide-based formulations and 20% urea foot care repair the skin barrier, relieve itching and tension, and provide intensive moisture. Range includes 20% urea foot care cream, peribucal protective balm, rich body balsam, and a natural nasal/lip fluid. Indicated for babies from 6 months, children, and adults depending on the SKU.

4Allergen-Specific Immunotherapy (Hyposensibilisierung)
CategoryAllergen immunotherapy
Description

Customized allergen-specific immunotherapy (hyposensibilisierung) preparations offered as a causal treatment for many allergies, enabling sustainable freedom from symptoms. Indicated for pollen allergy, house dust mite allergy, and other allergens. Prescriptions are placed by physicians through LETI's online ordering portal with order tracking, and the customized preparations are delivered to practices or pharmacies for patient administration.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Health Logistics
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Health Logistics serves as the contracted distribution partner for delivering products to German pharmacies. Located at Vichystr. 14, 76646 Bruchsal, Germany. Handles logistics and shipping of all goods to pharmacy customers.

leti.de
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Mass-market ceramide-based skincare brand with strong presence in sensitive/dry-skin and atopic-prone categories. Competes with LETI AT4 and LETI balm in consumer mindshare and pharmacy distribution.

2Dr. Wolff Group (Alpecin / Linola / Vagisan)
TypeDirect peer
Description

German mid-sized pharma company with dermatology and consumer health product lines (Linola for dry/eczema-prone skin) sold through German pharmacies. Closely comparable family-owned niche German dermo-pharma peer.

TypeDirect peer
Description

Global leader in allergen immunotherapy (SIT/sublingual) for pollen, mite, and other allergies. Directly comparable to LETI in the immunotherapy franchise, and a much larger incumbent in the same therapeutic category.

TypeDirect peer
Description

European allergen immunotherapy specialist with both diagnostic and therapeutic SIT products. Directly competes with LETI's immunotherapy and diagnostic offerings across DACH markets.

TypeDirect peer
Description

Danish-headquartered global allergen immunotherapy company with subcutaneous and sublingual products. Directly comparable to LETI's SIT/hyposensibilization franchise; competing in German-speaking Europe as well.

TypeBroad incumbent
Description

Beiersdorf's medical skincare brand for dry skin, atopic dermatitis, and sensitive skin, sold through German pharmacies. Sells adjacent product categories with much larger marketing spend and global reach.

TypeBroad incumbent
Description

French dermo-cosmetic brand for sensitive and reactive skin, including redness/rosacea products that overlap with LETI SR. Distributed through European pharmacies.

TypeBroad incumbent
Description

French dermatological skincare brand with Atoderm range for atopic and very dry skin, distributed in European pharmacies. Overlaps with LETI AT4 and LETI balm in the dry/barrier-repair category.

TypeBroad incumbent
Description

L'Oréal-owned dermatologist-recommended skincare brand with Lipikar range for atopic-prone skin. Overlaps with LETI AT4 in atopic dermatitis and sensitive skin categories globally.

TypeDirect peer
Description

Mid-sized German pharmaceutical company specializing in dermatology, neurology, and immunology products distributed via German pharmacies. Strong comparable as a German mid-market dermo/allergy pharma peer.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LETI Pharma

Dermatological Pharmaceuticalsleti.de

LETI Pharma is a privately-held Spanish pharmaceutical company founded in 1919 that develops and distributes medical skincare (LETI AT4, LETI SR, LETI balm) and allergen-specific immunotherapies through German pharmacies and online platforms for patients with atopic dermatitis, rosacea, dry skin, and allergies.

What LETI Pharma does

LETI Pharma, S.L.U. is a privately-held Spanish pharmaceutical company headquartered in Spain and founded in 1919 by a doctor and a pharmacist, focused on the intersection of dermatology and immunology. The company develops, manufactures, and distributes prescription-adjacent medical skincare and allergen-specific immunotherapies, targeting patients with atopic dermatitis (neurodermitis), sensitive or reddened skin including rosacea subtype I, very dry or compromised skin, and allergies such as pollen or house dust mite. The company celebrated its 100th anniversary in 2019 and operates as a family-owned business with continuous research activity since founding.

The product portfolio is organized into three dermatology lines — LETI AT4 (atopic-prone skin, addressing the four symptoms of dryness, itching, irritation, and superinfection risk, formulated with prebiotics such as alpha-glucan oligosaccharide, bisabolol, and barrier-repair ingredients), LETI SR (vascular protection line for rosacea and couperose using probiotic Lactobacillus Ferment), and LETI balm (intensive barrier repair with ceramides and 20% urea foot care) — alongside Hyposensibilisierung allergen-specific immunotherapy (SIT) offerings for causal allergy treatment. LETI AT4 has been clinically tested in over 50 studies, with reported user-survey outcomes including a 92% recommendation rate and 56% reduction in itching among children with neurodermitis.

The business model rests on B2B sales to the German pharmacy channel under AGB agreements, supported by an external sales force and pre-printed order forms; a separate Fachkreise (professional healthcare) channel — gated by DocCheck authentication — supplies physicians with diagnostic tools and customized SIT preparations ordered through a proprietary online portal (vacunas.leti.com) and delivered directly to practices. Distribution is executed by Health Logistics in Bruchsal, and products are additionally listed across at least nine German online pharmacy marketplaces (Shop Apotheke, DocMorris, Medpex, Aponeo, Apotal, Volksversand, Medikamente-per-Klick, MyCare, Apodiscounter). Revenue is generated from one-time product sales across all three segments (skincare, immunotherapy preparations, and diagnostic products), with no subscription or licensing pricing model disclosed. Pricing is not publicly disclosed and varies by pharmacy retail channel.

LETI Pharma firmographics

Firmographics
Name
LETI Pharma
Legal name
LETI Pharma, S.L.U.
Website
https://leti.de
Company type
Private
Founded year
1919
Operating status
Operating
Headcount range
11–50 employees
Short description
LETI Pharma is a privately-held Spanish pharmaceutical company founded in 1919 that develops and distributes medical skincare (LETI AT4, LETI SR, LETI balm) and allergen-specific immunotherapies through German pharmacies and online platforms for patients with atopic dermatitis, rosacea, dry skin, and allergies.
Ownership category
akta.pro rank

LETI Pharma industry classification

Industry
Product category
Dermatological Pharmaceuticals
NAICS
Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
SIC
Perfumes, Cosmetics & Other Toilet Preparations (2844), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIAAAK
Dermatology & Aesthetics Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYCRABAAAF
Dermocosmetics & Medical-Grade Skincare
SECONDARYCRABAAAG
Sensitive Skin & Barrier Repair
SECONDARYHLAIACAL
Dermatology Specialty Pharmaceuticals
SECONDARYCRADAMAF
Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)

Keywords

  • Dermatological skincare
  • Allergen immunotherapy
  • Atopic dermatitis care
  • Medical skin care
  • Allergy therapeutics

Where LETI Pharma is headquartered

Location

Headquarters

HQ city
Ismaning
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

LETI Pharma business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

  1. Medical Skincare Products: Sale of medical skincare products (LETI AT4, LETI SR, LETI balm lines) to pharmacies and end consumers through pharmacy channel.
  2. Specific Immunotherapy (SIT): Customized allergen immunotherapy preparations for allergy treatment, ordered through physicians and delivered to practices or pharmacies.
  3. Diagnostic Products: Sale of diagnostic tools for healthcare professionals in the Fachkreise (professional) segment.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

LETI Pharma product offering

Product offering

Core offering

LETI Pharma researches, develops, manufactures, and sells medical skincare products under three sub-brands — LETI AT4 (atopic-prone skin), LETI SR (sensitive/reddened skin and rosacea subtype I), and LETI balm (very dry and rough skin) — and provides allergen-specific immunotherapy (hyposensibilisierung) preparations for the causal treatment of pollen, house dust mite, and other allergies. Products are distributed primarily through pharmacies and physician practices across Germany and Western Europe, with a dedicated professional (Fachkreise) channel supplying diagnostic tools and customized immunotherapy to dermatologists and allergists.

Product overview

LETI Pharma is a Spanish pharmaceutical company founded in 1919 specializing in allergy treatments and medical skin care. The company operates three core product lines: (1) LETI AT4 - a comprehensive skin care range specifically formulated for dry, atopic-prone skin (atopic dermatitis/neurodermitis), addressing four key symptoms: skin dryness, itching, irritation, and tendency toward superinfections; (2) LETI SR - products for sensitive and reddened skin, couperose, and rosacea subtype I, offering double vascular protection; and (3) LETI balm - intensive care for very dry and rough skin with products for body, feet, lips, and nasal areas. Additionally, LETI Pharma offers allergen-specific immunotherapy (hyposensibilisierung) as a causal allergy treatment. Products are distributed through pharmacies and specialized online pharmacy platforms in Germany.

Differentiator

Problem solved

Functional benefit

Brands

  • LETI AT4: Dermatological skincare line specifically developed for dry skin prone to atopic dermatitis (neurodermatitis). The AT stands for 'Atopic' and the 4 represents the effectiveness against the 4 typical symptoms of atopic dermatitis: skin dryness, itching, skin irritations, and tendency to superinfections.
  • LETI SR
  • LETI balm

Products and services

  • LETI AT4 Medical skincare line for dry skin prone to atopic dermatitis (neurodermitis). Addresses the four typical symptoms — skin dryness, itching, skin irritations, and tendency toward superinfections — by repairing the skin barrier and restoring microbiome balance using prebiotic alpha-glucan oligosaccharide, bisabolol, and skin-barrier repair ingredients. Range includes shower/bath gel, intensive cream, body lotion, facial cream, and eye lid gel. Indicated for babies from 3 months, children, and adults.
  • LETI SR Medical skincare line for sensitive and reddened skin, including couperose and rosacea subtype I. Provides dual vascular protection that stabilizes capillary walls and strengthens supporting connective tissue, using probiotic Lactobacillus Ferment. Range includes micellar cleansing water, anti-redness serum, mineral SPF 30 facial cream, and an on-the-go anti-redness facial spray. Clinically tested to reduce redness and support skin recovery after facial laser treatments.
  • LETI balm Medical skincare line for very dry, rough, or stressed skin on the body, feet, lips, and peribucal area. Ceramide-based formulations and 20% urea foot care repair the skin barrier, relieve itching and tension, and provide intensive moisture. Range includes 20% urea foot care cream, peribucal protective balm, rich body balsam, and a natural nasal/lip fluid. Indicated for babies from 6 months, children, and adults depending on the SKU.
  • Allergen-Specific Immunotherapy (Hyposensibilisierung) Customized allergen-specific immunotherapy (hyposensibilisierung) preparations offered as a causal treatment for many allergies, enabling sustainable freedom from symptoms. Indicated for pollen allergy, house dust mite allergy, and other allergens. Prescriptions are placed by physicians through LETI's online ordering portal with order tracking, and the customized preparations are delivered to practices or pharmacies for patient administration.

Quantifiable outcome

  • 92% of users recommend LETI AT4 products (n=871, user survey trnd/TERRITORY GmbH, 01/2022)
  • +5 more outcomes

Companies that use LETI Pharma

Customer profile

Segments5 records

Ideal customer profiles3 records

LETI Pharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

LETI Pharma partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Health LogisticscoreChannel Partner/ Reseller/ DistributorHealth Logistics serves as the contracted distribution partner for delivering products to German pharmacies. Located at Vichystr. 14, 76646 Bruchsal, Germany. Handles logistics and shipping of all goods to pharmacy customers.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

LETI Pharma competitors and assessment

Company assessment

Broad incumbents

  • CeraVe (L'Oréal): Mass-market ceramide-based skincare brand with strong presence in sensitive/dry-skin and atopic-prone categories. Competes with LETI AT4 and LETI balm in consumer mindshare and pharmacy distribution.
  • Eucerin (Beiersdorf): Beiersdorf's medical skincare brand for dry skin, atopic dermatitis, and sensitive skin, sold through German pharmacies. Sells adjacent product categories with much larger marketing spend and global reach.
  • Avène (Pierre Fabre): French dermo-cosmetic brand for sensitive and reactive skin, including redness/rosacea products that overlap with LETI SR. Distributed through European pharmacies.
  • Bioderma (NAOS): French dermatological skincare brand with Atoderm range for atopic and very dry skin, distributed in European pharmacies. Overlaps with LETI AT4 and LETI balm in the dry/barrier-repair category.
  • La Roche-Posay (L'Oréal): L'Oréal-owned dermatologist-recommended skincare brand with Lipikar range for atopic-prone skin. Overlaps with LETI AT4 in atopic dermatitis and sensitive skin categories globally.

Direct peers

  • Dr. Wolff Group (Alpecin / Linola / Vagisan): German mid-sized pharma company with dermatology and consumer health product lines (Linola for dry/eczema-prone skin) sold through German pharmacies. Closely comparable family-owned niche German dermo-pharma peer.
  • Stallergenes Greer: Global leader in allergen immunotherapy (SIT/sublingual) for pollen, mite, and other allergies. Directly comparable to LETI in the immunotherapy franchise, and a much larger incumbent in the same therapeutic category.
  • HAL Allergy: European allergen immunotherapy specialist with both diagnostic and therapeutic SIT products. Directly competes with LETI's immunotherapy and diagnostic offerings across DACH markets.
  • ALK-Abelló: Danish-headquartered global allergen immunotherapy company with subcutaneous and sublingual products. Directly comparable to LETI's SIT/hyposensibilization franchise; competing in German-speaking Europe as well.
  • Wörwag Pharma: Mid-sized German pharmaceutical company specializing in dermatology, neurology, and immunology products distributed via German pharmacies. Strong comparable as a German mid-market dermo/allergy pharma peer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

LETI Pharma social profiles

Digital presence

LETI Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LETI Pharma leadership team

Management profile

Number of profiles

LETI Pharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LETI Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LETI Pharma

What does LETI Pharma do?

LETI Pharma researches, develops, manufactures, and sells medical skincare products under three sub-brands — LETI AT4 (atopic-prone skin), LETI SR (sensitive/reddened skin and rosacea subtype I), and LETI balm (very dry and rough skin) — and provides allergen-specific immunotherapy (hyposensibilisierung) preparations for the causal treatment of pollen, house dust mite, and other allergies. Products are distributed primarily through pharmacies and physician practices across Germany and Western Europe, with a dedicated professional (Fachkreise) channel supplying diagnostic tools and customized immunotherapy to dermatologists and allergists.

Is LETI Pharma a public or private company?

LETI Pharma is a private company. It is classified as family owned and is currently operating.

When was LETI Pharma founded?

LETI Pharma was founded in 1919. It employs 11 to 50 people.

Where is LETI Pharma based?

LETI Pharma is headquartered in Ismaning, Germany, in the Europe region.

How does LETI Pharma make money?

Three revenue lines are on record. Medical Skincare Products are the primary driver. The others are specific Immunotherapy (SIT) and diagnostic Products.

Who are LETI Pharma's main competitors?

Broad incumbents on record are CeraVe (L'Oréal), Eucerin (Beiersdorf), Avène (Pierre Fabre), Bioderma (NAOS) and La Roche-Posay (L'Oréal). Direct peers are Dr. Wolff Group (Alpecin / Linola / Vagisan), Stallergenes Greer, HAL Allergy, ALK-Abelló and Wörwag Pharma.

Does LETI Pharma have an API?

No public API is recorded for LETI Pharma.

What industry is LETI Pharma in?

LETI Pharma's product category is Dermatological Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals, with a secondary code of CRABAAAF, Dermocosmetics & Medical-Grade Skincare. Its NAICS code is 3254 and its SIC code is 2844.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals